...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Grading and Study of Biological Markers in Ductal Carcinoma in situ and Concurrent Infiltrating Ductal Carcinoma of Breast
【24h】

Grading and Study of Biological Markers in Ductal Carcinoma in situ and Concurrent Infiltrating Ductal Carcinoma of Breast

机译:乳腺导管原位癌和并发浸润性导管癌的生物学标记分级和研究

获取原文
           

摘要

Breast cancer is the most common cancer in women. Breast cancer has surpassed cervical cancer and is now the leading cause of cancer death; however, cervical cancer still remains common in rural areas.Aim: To assess the architectural pattern, nuclear grade, presence and absence of necrosis of Infiltrating Duct Carcinoma (IDC) and concurrent Ductal Carcinoma in situ (DCIS) and to correlate the biological markers of the two.Materials and Methods: The present study was carried out in the Department of Pathology, Father Muller Medical College, Mangaluru, Karnataka, India from January 2011 to February 2013. The mastectomy and lumpectomy specimens received in the histopathology laboratory were studied for the presence of IDC and concurrent DCIS. Haematoxylin and Eosin (H&E) staining for histological diagnosis and IHC analysis for ER, PR and Her-2eu was carried out. All the data were analysed using SSPS software version 13.0.Results: This study included total 60 cases of IDC (NOS) with concurrent DCIS. The mean age of patients was 48.6 years (SD ±11.21). Most common anatomic location was in the left breast. Majority of tumours were Grade 2 followed by Grade 3. The grades of the IDC and coexisting DCIS were concordant in 66.66% cases and 33.33% cases showed discordance. Also, 98.33% of cases showed similar expression of ER, PR and Her2eu in both the components. Statistically, a strong correlation was seen in the grades, ER, PR and Her2eu expression of IDC and DCIS (p<0.001).Conclusion: We found that to a great extent, it is possible to predict the biological behaviour of one component when that of the other is known and this may help in planning patient management when only DCIS is present.
机译:乳腺癌是女性中最常见的癌症。乳腺癌已经超过了宫颈癌,现在已经成为导致癌症死亡的主要原因。目的:评估浸润性导管癌(IDC)和并发导管原位癌(DCIS)的结构模式,核级,坏死的存在和不存在,并与之相关联。 材料和方法:本研究于2011年1月至2013年2月在印度卡纳塔克邦芒格鲁鲁父亲穆勒医学院的病理学系进行。本研究中接受了乳房切除术和肿块切除术标本。研究了组织病理学实验室是否存在IDC和并发的DCIS。使用苏木精和曙红(H&E)染色进行组织学诊断,并对ER,PR和Her-2 / neu进行IHC分析。所有数据均使用SSPS软件13.0版进行了分析。结果:本研究包括60例IDC(NOS)并发DCIS的病例。患者的平均年龄为48.6岁(SD±11.21)。最常见的解剖位置是在左乳房。多数肿瘤为2级,随后为3级。IDC和共存的DCIS的等级一致,分别为66.66%和33.33%。同样,有98.33%的病例在这两种成分中均表现出相似的ER,PR和Her2 / neu表达。从统计上看,IDC和DCIS的等级,ER,PR和Her2 / neu表达之间存在很强的相关性(p <0.001)。结论:我们发现在很大程度上可以预测生物学行为当已知一个组件的组件时,可以对其中一个组件的组件进行了解,如果仅存在DCIS,这可能有助于规划患者管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号